Acute lymphoblastic leukemia followed by chronic myelocytic leukemia

G. Tosato, J. Whang-Peng, A. S. Levine, D. G. Poplack

研究成果: 雜誌貢獻文章

12 引文 (Scopus)

摘要

Second hematologic malignancies occur rarely in patients previously treated for leukemia. This report describes a patient with acute lymphoblastic leukemia who remained in complete remission for 5 yr and then developed chronic myelocytic leukemia (CML). The original lymphoblasts were associated with a partial deletion of chromosome 21, while CML was associated with a classic Philadelphia marker, indicating the independent origin of the 2 leukemias.
原文英語
頁(從 - 到)1033-1036
頁數4
期刊Blood
52
發行號5
出版狀態已發佈 - 十二月 1 1978
對外發佈Yes

指紋

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Chromosomes
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Leukemia
Chromosomes, Human, Pair 21
Second Primary Neoplasms
Hematologic Neoplasms

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

引用此文

Tosato, G., Whang-Peng, J., Levine, A. S., & Poplack, D. G. (1978). Acute lymphoblastic leukemia followed by chronic myelocytic leukemia. Blood, 52(5), 1033-1036.

Acute lymphoblastic leukemia followed by chronic myelocytic leukemia. / Tosato, G.; Whang-Peng, J.; Levine, A. S.; Poplack, D. G.

於: Blood, 卷 52, 編號 5, 01.12.1978, p. 1033-1036.

研究成果: 雜誌貢獻文章

Tosato, G, Whang-Peng, J, Levine, AS & Poplack, DG 1978, 'Acute lymphoblastic leukemia followed by chronic myelocytic leukemia', Blood, 卷 52, 編號 5, 頁 1033-1036.
Tosato G, Whang-Peng J, Levine AS, Poplack DG. Acute lymphoblastic leukemia followed by chronic myelocytic leukemia. Blood. 1978 12月 1;52(5):1033-1036.
Tosato, G. ; Whang-Peng, J. ; Levine, A. S. ; Poplack, D. G. / Acute lymphoblastic leukemia followed by chronic myelocytic leukemia. 於: Blood. 1978 ; 卷 52, 編號 5. 頁 1033-1036.
@article{2cc5621d9bad484ca5ef9e090d84898e,
title = "Acute lymphoblastic leukemia followed by chronic myelocytic leukemia",
abstract = "Second hematologic malignancies occur rarely in patients previously treated for leukemia. This report describes a patient with acute lymphoblastic leukemia who remained in complete remission for 5 yr and then developed chronic myelocytic leukemia (CML). The original lymphoblasts were associated with a partial deletion of chromosome 21, while CML was associated with a classic Philadelphia marker, indicating the independent origin of the 2 leukemias.",
author = "G. Tosato and J. Whang-Peng and Levine, {A. S.} and Poplack, {D. G.}",
year = "1978",
month = "12",
day = "1",
language = "English",
volume = "52",
pages = "1033--1036",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "5",

}

TY - JOUR

T1 - Acute lymphoblastic leukemia followed by chronic myelocytic leukemia

AU - Tosato, G.

AU - Whang-Peng, J.

AU - Levine, A. S.

AU - Poplack, D. G.

PY - 1978/12/1

Y1 - 1978/12/1

N2 - Second hematologic malignancies occur rarely in patients previously treated for leukemia. This report describes a patient with acute lymphoblastic leukemia who remained in complete remission for 5 yr and then developed chronic myelocytic leukemia (CML). The original lymphoblasts were associated with a partial deletion of chromosome 21, while CML was associated with a classic Philadelphia marker, indicating the independent origin of the 2 leukemias.

AB - Second hematologic malignancies occur rarely in patients previously treated for leukemia. This report describes a patient with acute lymphoblastic leukemia who remained in complete remission for 5 yr and then developed chronic myelocytic leukemia (CML). The original lymphoblasts were associated with a partial deletion of chromosome 21, while CML was associated with a classic Philadelphia marker, indicating the independent origin of the 2 leukemias.

UR - http://www.scopus.com/inward/record.url?scp=0018249150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018249150&partnerID=8YFLogxK

M3 - Article

C2 - 279358

AN - SCOPUS:0018249150

VL - 52

SP - 1033

EP - 1036

JO - Blood

JF - Blood

SN - 0006-4971

IS - 5

ER -